Oestrogen receptor negative breast cancers exhibit high cytokine content

被引:275
|
作者
Chavey, Carine
Bibeau, Frederic
Gourgou-Bourgade, Sophie
Burlinchon, Sandrine
Boissiere, Florence
Laune, Daniel
Roques, Sylvie
Lazennec, Gwendal
机构
[1] Univ Montpellier I, INSERM, U844, F-34091 Montpellier, France
[2] CRLC Val Aurelle, Dept Pathol, F-34298 Montpellier, France
[3] CRLC Val Aurelle, Biostat Unit, F-34298 Montpellier, France
[4] Ctr Pharmacol & Biotechnol Sante, Fac Pharm, CNRS, UMR 5160, F-34093 Montpellier, France
关键词
D O I
10.1186/bcr1648
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction An emerging hypothesis suggests that cytokines could play an important role in cancer as potential modulators of angiogenesis and leucocyte infiltration. Methods A novel multiplexed flow cytometry technology was used to measure the expression of 17 cytokines ( IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 [p70], IL-13, IL-17, granulocyte colony-stimulating factor [CSF], granulocyte-macrophage CSF, IFN-gamma, monocyte chemoattractant protein [MCP]-1, macrophage inflammatory protein [MIP]-1 beta, tumour necrosis factor [TNF]-alpha) at the protein level in 105 breast carcinoma. B lymphocyte, T lymphocyte and macrophage levels were determined by immunohistochemistry. Results Fourteen of the 17 cytokines were expressed in breast carcinoma, whereas only nine cytokines could be detected in normal breast. Most cytokines were more abundant in breast carcinoma than in normal breast, with IL-6, IL-8, granulocyte CSF, IFN-gamma, MCP-1 and MIP-1 beta being very abundant. IL-2, IL-6, IL-8, IL-10, IFN-gamma, MCP-1, MIP-1 beta and TNF-alpha, and to a lesser extent IL-1 beta and IL-13 exhibited levels of expression that were inversely correlated to oestrogen receptor and progesterone receptor status. Most cytokines were not correlated with age at cancer diagnosis, tumour size, histological type, or lymph node status. However, IL-1 beta, IL-6, IL-8, IL-10, IL-12, MCP-1 and MIP-1 beta were more abundant in high-grade tumours than in low-grade tumours. In addition, IL-8 and MIP-1 beta were expressed to a greater degree in HER2-positive than in HER2-negative patients. The expression of most of the studied cytokines was correlated to levels of activator protein-1, which is known to regulate numerous cytokines. Overexpression of MCP-1 and MIP-1 beta were linked to B lymphocyte, T lymphocyte and macrophage infiltration, whereas high levels of IL-8 were correlated with high macrophage content in tumour. Moreover, IL-8 positive tumours exhibited increased vascularization. Conclusion We found that multiple cytokines were overexpressed in oestrogen receptor negative breast carcinoma, and that the three major cytokines - MCP-1, MIP-1 beta and IL-8 - were correlated with inflammatory cell component, which could account for the aggressiveness of these tumours.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Oestrogen receptor negative breast cancers exhibit high cytokine content
    Carine Chavey
    Frédéric Bibeau
    Sophie Gourgou-Bourgade
    Sandrine Burlinchon
    Florence Boissière
    Daniel Laune
    Sylvie Roques
    Gwendal Lazennec
    Breast Cancer Research, 9
  • [2] The progesterone receptor has a prognostic value in oestrogen receptor negative breast cancers
    Huang, H. J.
    Neven, P.
    Drijkoningen, M.
    Paridaens, R.
    Berteloot, P.
    Amant, F.
    Vergote, I.
    Christiaens, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 103 - 104
  • [3] Consistency of oestrogen receptor scoring of breast cancers
    McGregor, AH
    Lessells, A
    Alexander, F
    Anderson, T
    JOURNAL OF PATHOLOGY, 1998, 186 : 22A - 22A
  • [4] The origins of oestrogen receptor negative breast cancer
    D Craig Allred
    Breast Cancer Research, 9
  • [5] The origins of oestrogen receptor negative breast cancer
    Allred, D. Craig
    BREAST CANCER RESEARCH, 2007, 9 (Suppl 2)
  • [6] Analysis of oestrogen receptor α and β and variants in breast cancers and surrounds
    Mosquera, JM
    Shaw, JA
    Dearing, SJ
    Walker, RA
    JOURNAL OF PATHOLOGY, 2000, 190 : 17A - 17A
  • [7] Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
    Skliris, G. P.
    Leygue, E.
    Curtis-Snell, L.
    Watson, P. H.
    Murphy, L. C.
    BRITISH JOURNAL OF CANCER, 2006, 95 (05) : 616 - 626
  • [8] Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
    G P Skliris
    E Leygue
    L Curtis-Snell
    P H Watson
    L C Murphy
    British Journal of Cancer, 2006, 95 : 616 - 626
  • [9] Chemotherapy for oestrogen-receptor-negative breast cancer
    Yerushalmi, Rinat
    Gelmon, Karen
    LANCET, 2008, 371 (9606): : 4 - 5
  • [10] Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group
    Ahmed, Syed Salahuddin
    Thike, Aye Aye
    Zhang, Kathryn
    Lim, Jeffrey Chun Tatt
    Puay Hoon Tan
    JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (04) : 320 - 326